Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Trying to mimic the “Berlin Patient” cure, researchers edited the CCR5 gene in the immune stem cells of a man with leukemia and HIV.
This amfAR grant hopes to find out. It’s part of $1.16 million in new funding from ARCHE.
It likely aided the human species’s expansion but was eventually outmatched by an evolving virus.
Researchers conducted an analysis of hep C treatment outcomes in those also living with HIV in Western nations.
In a recent study, the molecule delayed viral rebound in latently infected cells after antiretrovirals were discontinued.
How true is his statement? These facts add context.
Check out these party pics from Kiehl’s 10th annual LifeRide for amfAR, the Foundation for AIDS Research.
A guest blog post by Andrew Ngo, age 18.
After almost a decade on antiretroviral therapy, half of study participants still had HIV in immune cells in their brain and spinal fluid.
Previous research has shown that long interruptions are not safe—but what about shorter, more closely monitored gaps in treatment?
The circumstances of this case are so highly unique, the prospect of replicating it are quite uncertain.
Any HIV cure on the horizon will have to tackle macrophage immune cells as well as CD4 T Cells, a study indicates.
The increasing mastery over the virus is one of humanity’s crowning achievements.
Interfering with this receptor on immune cells could have harmful health consequences.
This finding may eventually make HIV gene therapies more affordable and accessible.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.